Chemically modified recombinant human sulfamidase (SOBI003) in mucopolysaccharidosis IIIA patients: Results from an open, non-controlled, multicenter study.
Mol Genet Metab
; 136(4): 249-259, 2022 08.
Article
in En
| MEDLINE
| ID: mdl-35835061
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mucopolysaccharidosis III
Type of study:
Clinical_trials
Aspects:
Patient_preference
Limits:
Child
/
Child, preschool
/
Humans
/
Infant
Language:
En
Journal:
Mol Genet Metab
Journal subject:
BIOLOGIA MOLECULAR
/
BIOQUIMICA
/
METABOLISMO
Year:
2022
Document type:
Article
Country of publication:
United States